Stratification of asthma phenotypes by airway proteomic signatures.

Schofield, James P R; Burg, Dominic; Nicholas, Ben; Strazzeri, Fabio; Brandsma, Joost; Staykova, Doroteya; Folisi, Caterina; Bansal, Aruna T; Xian, Yang; Guo, Yike; Rowe, Anthony; Corfield, Julie; Wilson, Susan; Ward, Jonathan; Lutter, Rene; Shaw, Dominick E; Bakke, Per S; Caruso, Massimo; Dahlen, Sven-Erik; Fowler, Stephen J; ... (2019). Stratification of asthma phenotypes by airway proteomic signatures. Journal of allergy and clinical immunology, 144(1), pp. 70-82. Elsevier 10.1016/j.jaci.2019.03.013

[img] Text
stratification of asthma phenotypes by airway proteomic signatures_2019.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

BACKGROUND

Stratification by eosinophil and neutrophil counts increases our understanding of asthma and helps target therapy, but there is room for improvement in our accuracy in prediction of treatment responses and a need for better understanding of the underlying mechanisms.

OBJECTIVE

We sought to identify molecular subphenotypes of asthma defined by proteomic signatures for improved stratification.

METHODS

Unbiased label-free quantitative mass spectrometry and topological data analysis were used to analyze the proteomes of sputum supernatants from 246 participants (206 asthmatic patients) as a novel means of asthma stratification. Microarray analysis of sputum cells provided transcriptomics data additionally to inform on underlying mechanisms.

RESULTS

Analysis of the sputum proteome resulted in 10 clusters (ie, proteotypes) based on similarity in proteomic features, representing discrete molecular subphenotypes of asthma. Overlaying granulocyte counts onto the 10 clusters as metadata further defined 3 of these as highly eosinophilic, 3 as highly neutrophilic, and 2 as highly atopic with relatively low granulocytic inflammation. For each of these 3 phenotypes, logistic regression analysis identified candidate protein biomarkers, and matched transcriptomic data pointed to differentially activated underlying mechanisms.

CONCLUSION

This study provides further stratification of asthma currently classified based on quantification of granulocytic inflammation and provided additional insight into their underlying mechanisms, which could become targets for novel therapies.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Pneumologie (Pädiatrie)
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Pneumology

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1097-6825

Publisher:

Elsevier

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

24 Jan 2020 14:37

Last Modified:

20 Jul 2022 10:01

Publisher DOI:

10.1016/j.jaci.2019.03.013

PubMed ID:

30928653

Additional Information:

U-BIOPRED Study Group: Singer Florian and Krüger Linn

Uncontrolled Keywords:

Asthma biomarkers eosinophils neutrophils proteomics

BORIS DOI:

10.7892/boris.137490

URI:

https://boris.unibe.ch/id/eprint/137490

Actions (login required)

Edit item Edit item
Provide Feedback